Brackett L E, Daly J W
Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
J Pharmacol Exp Ther. 1991 Apr;257(1):205-13.
Adenosine analogs were tested for their ability to relax carbachol-contracted trachea in vitro. The rank order of potency was: 5'-N-ethylcarboxamidoadenosine (NECA) greater than 2-chloroadenosine (2-CIADO) greater than 5'-chloroadenosine = N6-R-1-phenyl-2-propyladenosine (R-PIA) greater than N6-cyclohexyladenosine greater than 2-phenylaminoadenosine (CV1808) greater than 5'-methylthioadenosine (MTA). The rank order of potency for NECA, 2-CIADO and R-PIA is characteristic of an A2 subtype of adenosine receptor. 8-Para-sulfophenyltheophylline (8-p-ST) and 8-cyclopentyl-1, 3-dipropylxanthine (DPCPX), were used to antagonize tracheal relaxation elicited by adenosine analogs. 8-p-ST antagonized the 2-CIADO, N6-cyclohexyladenosine, R-PIA and 5'-chloroadenosine responses, but had little or no effect on the CV1808 and MTA responses. 8-p-ST antagonized responses to NECA at concentrations of NECA up to approximately 30 microM, but had no effect on responses to higher concentrations of NECA. The differences in antagonist potency of 8-p-ST and the clear biphasic response of NECA are indicative of at least two mechanisms of adenosine analog action leading to tracheal relaxation. One mechanism is mediated through a xanthine-sensitive site, at which NECA acted in a potent manner, whereas the other mechanism or mechanisms are insensitive to blockade by xanthines and account for the effects of action of MTA and CV1808, as well as for NECA at high concentrations. The low potency of the A1-selective antagonist DPCPX indicates that the xanthine-sensitive site is an A2 type receptor.(ABSTRACT TRUNCATED AT 250 WORDS)
对腺苷类似物进行了体外舒张卡巴胆碱收缩气管能力的测试。效力顺序为:5'-N-乙基甲酰胺基腺苷(NECA)>2-氯腺苷(2-CIADO)>5'-氯腺苷 = N6-R-1-苯基-2-丙基腺苷(R-PIA)>N6-环己基腺苷>2-苯氨基腺苷(CV1808)>5'-甲硫基腺苷(MTA)。NECA、2-CIADO和R-PIA的效力顺序是腺苷受体A2亚型的特征。8-对磺基苯甲基黄嘌呤(8-p-ST)和8-环戊基-1,3-二丙基黄嘌呤(DPCPX)用于拮抗腺苷类似物引起的气管舒张。8-p-ST拮抗2-CIADO、N6-环己基腺苷、R-PIA和5'-氯腺苷的反应,但对CV1808和MTA的反应几乎没有影响。在NECA浓度高达约30 microM时,8-p-ST拮抗对NECA的反应,但对更高浓度NECA的反应没有影响。8-p-ST拮抗剂效力的差异以及NECA明显的双相反应表明,至少有两种腺苷类似物导致气管舒张的作用机制。一种机制是通过黄嘌呤敏感位点介导的,NECA在该位点以强效方式起作用,而另一种或多种机制对黄嘌呤的阻断不敏感,这解释了MTA和CV1808的作用效果,以及高浓度NECA的作用效果。A1选择性拮抗剂DPCPX的低效表明黄嘌呤敏感位点是A2型受体。(摘要截短于250字)